What question did this study set out to answer?

To analyze the long-term impact of treatment for neovascular age-related macular degeneration on vision-related quality of life.

April 22, 2026

View Full Paper

The long‐term impact of neovascular age‐related macular degeneration undergoing routine treatment in first and second eyes on vision‐related quality‐of‐life: FASBAT Report 3

AAArchana Airody RHRachel L. W. HansonYork Teaching Hospital NHS Foundation Trust IBIsabel Bunola‐HadfieldYork Teaching Hospital NHS Foundation Trust

Key Points

To analyze the long-term impact of treatment for neovascular age-related macular degeneration on vision-related quality of life.
Evaluated vision-related quality of life in patients with unilateral treated neovascular age-related macular degeneration
Assessed changes following development and treatment in the second eye
Vision-related quality of life remains stable in treated unilateral cases
Clinically meaningful decline in quality of life occurs with bilateral involvement that does not recover

Abstract

Long-term VRQoL remains stable in unilateral treated nAMD. However, a clinically meaningful reduction in VRQoL occurs following development and treatment in the second eye which does not recover. It is important to offer appropriate support when the first and then second eye develop nAMD.

KI fragen

Bookmark

View Full Paper

Cite This Study

Airody et al. (Mon,) studied this question.

synapsesocial.com/papers/69e865fd6e0dea528ddea6b7 https://doi.org/https://doi.org/10.1111/aos.70150

KI fragen

Bookmark

View Full Paper